
Brii Biosciences Investor Relations Material
Latest events

H1 2025
Brii Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Brii Biosciences Limited
Access all reports
Brii Biosciences Limited is a biotechnology company focused on developing therapies for infectious diseases and central nervous system disorders. The company specializes in innovative treatments for conditions such as hepatitis B, HIV, and drug-resistant bacterial infections. It leverages partnerships with global research institutions and biopharmaceutical firms to advance its pipeline through clinical development and regulatory approval. The company is headquartered in Beijing, China, and its shares are listed on the Hong Kong Stock Exchange (HKEX).
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
2137
Country
🇭🇰 Hong Kong